From left, Roscosmos cosmonaut Andrey Fedyaev, NASA astronauts Jack Hathaway and Jessica Meir, and ESA (European Space Agency) astronaut Sophie Adenot pose next to their mission insignia inside the Astronaut Crew Quarters in the Neil A. Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida on Monday, Feb. 9, 2026. NASA’s SpaceX Crew-12 crew members will launch aboard a SpaceX Dragon spacecraft and Falcon 9 to the International Space Station no earlier than 5:15 a.m. EST on Friday, Feb. 13, from Cape Canaveral Space Force Station’s Space Launch Complex 40.
During their eight-month mission, Crew-12 will conduct a variety of science experiments to advance research and technology for future Moon and Mars missions and benefit humanity back on Earth. This research includes studies of pneumonia-causing bacteria to improve treatments, on-demand intravenous fluid generation for future space missions, automated plant health monitoring, investigations of plant and nitrogen-fixing microbe interactions to enhance food production in space, and research on how physical characteristics may affect blood flow during spaceflight.
Image credit: NASA/Kim Shiflett
2026年2月9日星期一，在佛罗里达州NASA肯尼迪航天中心的尼尔·阿姆斯特朗操作与检修大楼宇航员宿舍内，（从左至右）俄罗斯国家航天集团宇航员安德烈·费佳耶夫、NASA宇航员杰克·海瑟薇和杰西卡·梅尔，以及ESA（欧洲航天局）宇航员索菲·阿德诺在任务徽章旁合影。NASA SpaceX Crew-12机组人员计划不早于美国东部时间2月13日周五凌晨5:15，搭乘SpaceX龙飞船与猎鹰9号火箭，从卡纳维拉尔角太空军基地40号航天发射复合体发射升空前往国际空间站。
在为期八个月的任务中，Crew-12将开展各种科学实验，以推动未来月球和火星任务的研究与技术发展，并造福地球人类。这些研究涵盖：针对致肺炎细菌的研究以改进治疗方法、面向未来太空任务的按需制备静脉输液技术、植物健康自动化监测、旨在提高太空食物产量的植物与固氮微生物相互作用调查，以及身体特征如何影响太空飞行期间血液流动的研究。
影像来源: NASA/Kim Shiflett
